Article info

Download PDFPDF
Value of screening for and treating pre-diabetes is reduced by low test accuracy and indirect evidence of impact on patient important outcomes

Authors

  • Neri A Alvarez-Villalobos Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA Department of Research Unit, University Hospital ‘Dr Jose E Gonzalez’ Autonomous University of Nuevo Leon, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Rene Rodriguez-Gutierrez Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA Division of Endocrinology, University Hospital ‘Dr Jose E Gonzalez’ Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon, Mexico PubMed articlesGoogle scholar articles
  • Victor M Montori Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Victor M Montori, Knowledge and Evaluation Research Unit and Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA; Montori.Victor{at}mayo.edu
View Full Text

Citation

Alvarez-Villalobos NA, Rodriguez-Gutierrez R, Montori VM
Value of screening for and treating pre-diabetes is reduced by low test accuracy and indirect evidence of impact on patient important outcomes

Publication history

  • Accepted June 23, 2017
  • First published July 22, 2017.
Online issue publication 
October 04, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.